Current Drug Development Projects

This is a preview of the Data Table. Only the first three rows are displayed.
Title	Disorder	PI/Lead Investigator	Institution
Developing nonmuscle II inhibitors for substance use relapse/a>	Substance Use Disorder	Miller, Courtney A	Scripps Florida
Non-addictive Angiotensin AT2 inhibitors for neuropathic pain relief	Pain	Katritch, Vsevolod	University of Southern California
Small Molecule Mitochondria-Targeted Therapeutics for AD	Alzheimers Disease	Trushina, Eugenia	Mayo Clinic Rochester
Developing a kinase inhibitor drug to treat spinal cord injury	Spinal Cord Injury	Al-Ali, Hassan	University of Miami School of Medicine
Development of selective cannabinoid receptor 2 agonists for treatment of addiction	Substance Use Disorder	Shamloo, Mehrdad	Stanford University
Optimization of EP2 Antagonists for Post-Seizure Cognitive Deficits	Cognitive Impairment Post-Seizure	Ganesh, Thota	Emory University
Discovery of PSD95 protein-protein interaction inhibitors as novel non-opioid analgesics	Pain	Florio, Stephanie K	Anagin